<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Evans KT</submitter><funding>Feodor-Lynen fellowship from the Alexander-von-Humboldt Stiftung</funding><funding>Canadian Institutes of Health Research Postdoctoral Fellowship</funding><funding>NIBIB NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute</funding><funding>NINDS NIH HHS</funding><funding>NCI NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | National Institutes of Health</funding><funding>Division of Intramural Research, National Institute of Allergy and Infectious Diseases</funding><funding>NIGMS NIH HHS</funding><pagination>1848-1859</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11414741</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(12)</volume><pubmed_abstract>Breast cancer brain metastasis (BCBM) is a lethal disease with no effective treatments. Prior work has shown that brain cancers and metastases are densely infiltrated with anti-inflammatory, protumourigenic tumour-associated macrophages, but the role of brain-resident microglia remains controversial because they are challenging to discriminate from other tumour-associated macrophages. Using single-cell RNA sequencing, genetic and humanized mouse models, we specifically identify microglia and find that they play a distinct pro-inflammatory and tumour-suppressive role in BCBM. Animals lacking microglia show increased metastasis, decreased survival and reduced natural killer and T cell responses, showing that microglia are critical to promote anti-tumour immunity to suppress BCBM. We find tha</pubmed_abstract><journal>Nature cell biology</journal><pubmed_title>Microglia promote anti-tumour immunity and suppress breast cancer brain metastasis.</pubmed_title><pmcid>PMC11414741</pmcid><funding_grant_id>U54-CA-217378</funding_grant_id><funding_grant_id>T32NS121727-01</funding_grant_id><funding_grant_id>F31 CA281331</funding_grant_id><funding_grant_id>NIHT32EB009418</funding_grant_id><funding_grant_id>T32 NS082174</funding_grant_id><funding_grant_id>K99 CA267160</funding_grant_id><funding_grant_id>T32NS082174</funding_grant_id><funding_grant_id>R01 CA237376</funding_grant_id><funding_grant_id>R01NS120060</funding_grant_id><funding_grant_id>1K99CA267160-01</funding_grant_id><funding_grant_id>T32 NS121727</funding_grant_id><funding_grant_id>T32AI 0602573</funding_grant_id><funding_grant_id>F31CA281331</funding_grant_id><funding_grant_id>R01CA237376-01A1</funding_grant_id><funding_grant_id>T32 GM136624</funding_grant_id><funding_grant_id>T32 GM008620</funding_grant_id><funding_grant_id>U54 CA217378</funding_grant_id><funding_grant_id>R01 NS120060</funding_grant_id><funding_grant_id>P30 CA062203</funding_grant_id><funding_grant_id>T32 EB009418</funding_grant_id><funding_grant_id>T32GM136624</funding_grant_id><pubmed_authors>Orujyan D</pubmed_authors><pubmed_authors>McMullen TP</pubmed_authors><pubmed_authors>Blurton-Jones M</pubmed_authors><pubmed_authors>Pridans C</pubmed_authors><pubmed_authors>Villalta SA</pubmed_authors><pubmed_authors>Evans KT</pubmed_authors><pubmed_authors>Insua-Rodriguez J</pubmed_authors><pubmed_authors>Lev T</pubmed_authors><pubmed_authors>Blake K</pubmed_authors><pubmed_authors>Green KN</pubmed_authors><pubmed_authors>Coburn MA</pubmed_authors><pubmed_authors>Longworth A</pubmed_authors><pubmed_authors>Nguyen QH</pubmed_authors><pubmed_authors>Lawson DA</pubmed_authors><pubmed_authors>Edwards RA</pubmed_authors><pubmed_authors>Ma D</pubmed_authors><pubmed_authors>Oganyan AK</pubmed_authors><pubmed_authors>Hernandez GA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Microglia promote anti-tumour immunity and suppress breast cancer brain metastasis.</name><description>Breast cancer brain metastasis (BCBM) is a lethal disease with no effective treatments. Prior work has shown that brain cancers and metastases are densely infiltrated with anti-inflammatory, protumourigenic tumour-associated macrophages, but the role of brain-resident microglia remains controversial because they are challenging to discriminate from other tumour-associated macrophages. Using single-cell RNA sequencing, genetic and humanized mouse models, we specifically identify microglia and find that they play a distinct pro-inflammatory and tumour-suppressive role in BCBM. Animals lacking microglia show increased metastasis, decreased survival and reduced natural killer and T cell responses, showing that microglia are critical to promote anti-tumour immunity to suppress BCBM. We find tha</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Dec</publication><modification>2026-06-01T10:05:23.356Z</modification><creation>2025-04-04T08:22:18.623Z</creation></dates><accession>S-EPMC11414741</accession><cross_references><pubmed>37957324</pubmed><doi>10.1038/s41556-023-01273-y</doi></cross_references></HashMap>